Toll-like receptor activity in Recurrent Aphthous Ulceration

Journal of Oral Pathology and Medicine

Volumn 38, Issue 3, 2009, Pages 289-298

  Borra, Ricardo Carneiro ^a   De Mesquita Barros, Fabiana ^a   De Andrade Lotufo, Mônica ^a   Villanova, Fabiolla Elizabeth ^b   Andrade, Priscila Maria ^b  

^a IBIRAPUERA UNIVERSITY   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Aphthous stomatitis; Oral ulcer; Th1 cells; Toll like receptor 2

Indexed keywords

CD14 ANTIGEN; FLAGELLIN; IMIQUIMOD; LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN EXPRESSION; APHTHOUS ULCER; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; LISTERIA MONOCYTOGENES; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SALIVA LEVEL; SEROLOGY;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD14; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; FEMALE; HUMANS; LEUKOCYTES, MONONUCLEAR; LINEAR MODELS; MALE; MIDDLE AGED; SALIVA; STOMATITIS, APHTHOUS; TH1 CELLS; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 61349189119     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00743.x     Document Type: Article

References (56)

1. Ship JA, Chavez EM, Doerr PA, et al. Recurrent aphthous stomatitis. Quintessence Int 2000 31 : 95 112.
2. Freysdottir J, Zhang S, Tilakaratne WM, et al. Oral biopsies from patients with orofacial granulomatosis with histology resembling Crohn's disease have a prominent Th1 environment. Inflamm Bowel Dis 2007 13 : 439 45.
3. Garside P, Mowat AM, Khoruts A. Oral tolerance in disease. Gut 1999 44 : 137 42.
4. Buno IJ, Huff JC, Weston WL, et al. Elevated levels of interferon gamma, tumor necrosis factor alpha, interleukins 2, 4, and 5, but not interleukin 10, are present in recurrent aphthous stomatitis. Arch Dermatol 1998 134 : 827 31.
5. Borra RC, Andrade PM, Silva ID, et al. The Th1/Th2 immune-type response of the recurrent aphthous ulceration analyzed by cDNA microarray. J Oral Pathol Med 2004 33 : 140 6.
6. Lewkowicz N, Lewkowicz P, Banasik M, et al. Predominance of Type 1 cytokines and decreased number of CD4(+)CD25(+high) T regulatory cells in peripheral blood of patients with recurrent aphthous ulcerations. Immunol Lett 2005 99 : 57 62.
7. Albanidou-Farmaki E, Markopoulos AK, Kalogerakou F, et al. Detection, enumeration and characterization of T helper cells secreting type 1 and type 2 cytokines in patients with recurrent aphthous stomatitis. Tohoku J Exp Med 2007 212 : 101 5.
8. Miyamoto NT Jr., Borra RC, Abreu M, et al. Immune-expression of HSP27 and IL-10 in recurrent aphthous ulceration. J Oral Pathol Med 2008 37 : 462 7.
9. Taylor LJ, Bagg J, Walker DM, et al. Increased production of tumour necrosis factor by peripheral blood leukocytes in patients with recurrent oral aphthous ulceration. J Oral Pathol Med 1992 21 : 21 5.
10. Perri AJ III., Hsu S. A review of thalidomide's history and current dermatological applications. Dermatol Online J 2003 9 : 5.
11. Thornhill MH, Baccaglini L, Theaker E, et al. A randomized, double-blind, placebo-controlled trial of pentoxifylline for the treatment of recurrent aphthous stomatitis. Arch Dermatol 2007 143 : 463 70.
12. Gorsky M, Epstein J, Rabenstein S, et al. Topical minocycline and tetracycline rinses in treatment of recurrent aphthous stomatitis: a randomized cross-over study. Dermatol Online J 2007 13 : 1.
13. Preshaw PM, Grainger P, Bradshaw MH, et al. Subantimicrobial dose doxycycline in the treatment of recurrent oral aphthous ulceration: a pilot study. J Oral Pathol Med 2007 36 : 236 40.
14. Robinson ND, Guitart J. Recalcitrant, recurrent aphthous stomatitis treated with etanercept. Arch Dermatol 2003 139 : 1259 62.
15. Jacobi A, Debus D, Schuler G, et al. Infliximab in a patient with refractory mucosal aphthosis. J Eur Acad Dermatol Venereol 2008 22 : 109 10.
16. Vujevich J, Zirwas M. Treatment of severe, recalcitrant, major aphthous stomatitis with adalimumab. Cutis 2005 76 : 129 32.
17. Bonifati C, Ameglio F. Cytokines in psoriasis. Int J Dermatol 1999 38 : 241 51.
18. Frassanito MA, Dammacco R, Cafforio P, et al. Th1 polarization of the immune response in Behcet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum 1999 42 : 1967 74.
19. Ehrenstein MR, Evans JG, Singh A, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 2004 200 : 277 85.
20. Van Deventer SJ. Tumour necrosis factor and Crohn's disease. Gut 1997 40 : 443 8.
21. Fitzgerald KA, O'neill LA. The role of the interleukin-1/Toll-like receptor superfamily in inflammation and host defence. Microbes Infect 2000 2 : 933 43.
22. Netea MG, Van Der Meer JW, Sutmuller RP, et al. From the Th1/Th2 paradigm towards a Toll-like receptor/T-helper bias. Antimicrob Agents Chemother 2005 49 : 3991 6.
23. Qi H, Denning TL, Soong L. Differential induction of interleukin-10 and interleukin-12 in dendritic cells by microbial toll-like receptor activators and skewing of T-cell cytokine profiles. Infect Immun 2003 71 : 3337 42.
24. Shen H, Kanoh M, Liu F, et al. Modulation of the immune system by Listeria monocytogenes-mediated gene transfer into mammalian cells. Microbiol Immunol 2004 48 : 329 37.
25. Yeung VP, Gieni RS, Umetsu DT, et al. Heat-killed Listeria monocytogenes as an adjuvant converts established murine Th2-dominated immune responses into Th1-dominated responses. J Immunol 1998 161 : 4146 52.
26. Re F, Strominger JL. IL-10 released by concomitant TLR2 stimulation blocks the induction of a subset of Th1 cytokines that are specifically induced by TLR4 or TLR3 in human dendritic cells. J Immunol 2004 173 : 7548 55.
27. Dillon S, Agrawal A, Van Dyke T, et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 2004 172 : 4733 43.
28. Agrawal S, Agrawal A, Doughty B, et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen- activated protein kinase and c-Fos. J Immunol 2003 171 : 4984 9.
29. Liew FY, Xu D, Brint EK, et al. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev 2005 5 : 446 58.
30. Chakrabarty AK, Mraz S, Geisse JK, et al. Aphthous ulcers associated with imiquimod and the treatment of actinic cheilitis. J Am Acad Dermatol 2005 52 : 35 7.
31. Zalaudek I, Petrillo G, Argenziano G. Aphthous ulcers and imiquimod. J Am Acad Dermatol 2005 53 : 360 1.
32. Wuensch KL, Jenkins KW, Poteat GM. Misanthropy, idealism, and attitudes towards animals. Anthrozoös 2002 15 : 139 49.
33. Hammer Ø, Harper DAT, Ryan PD. PAST: Paleontological Statistics Software Package for Education and Data Analysis. Palaeontol Electronica 2001 4 : 9.
34. Palazzo M, Gariboldi S, Zanobbio L, et al. Cross-talk among Toll-like receptors and their ligands. Int Immunol 2008 20 : 709 18.
35. Savage NW, Seymour GJ. Specific lymphocytotoxic destruction of autologous epithelial cell targets in recurrent aphthous stomatitis. Aust Dent J 1994 39 : 98 104.
36. Ida JA, Shrestha N, Desai S, et al. A whole blood assay to assess peripheral blood dendritic cell function in response to Toll-like receptor stimulation. J Immunol Methods 2006 310 : 86 99.
37. Amel Kashipaz MR, Swinden D, Todd I, et al. Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clin Exp Immunol 2003 132 : 360 5.
38. Schwandner R, Dziarski R, Wesche H, et al. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 1999 274 : 17406 9.
39. Aliprantis AO, Yang RB, Mark MR, et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science (New York, NY) 1999 285 : 736 9.
40. Flo TH, Halaas O, Lien E, et al. Human toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide. J Immunol 2000 164 : 2064 9.
41. Raymond T, Schaller M, Hogaboam CM, et al. Toll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation. Proc Am Thorac Soc 2007 4 : 635 41.
42. Netea MG, Kullberg BJ, De Jong DJ, et al. NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease. Eur J Immunol 2004 34 : 2052 9.
43. Sutmuller RP, Den Brok MH, Kramer M, et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006 116 : 485 94.
44. Liu H, Komai-Koma M, Xu D, et al. Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci USA 2006 103 : 7048 53.
45. Lewkowicz N, Lewkowicz P, Dzitko K, et al. Dysfunction of CD4(+)CD25(high) T regulatory cells in patients with recurrent aphthous stomatitis. J Oral Pathol Med 2008 37 : 454 61.
46. Zanin-Zhorov A, Cahalon L, Tal G, et al. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest 2006 116 : 2022 32.
47. Hasan A, Childerstone A, Pervin K, et al. Recognition of a unique peptide epitope of the mycobacterial and human heat shock protein 65-60 antigen by T cells of patients with recurrent oral ulcers. Clin Exp Immunol 1995 99 : 392 7.
48. Habich C, Burkart V. Heat shock protein 60: regulatory role on innate immune cells. Cell Mol Life Sci 2007 64 : 742 51.
49. Versteeg D, Dol E, Hoefer IE, et al. Toll-like receptor 2 and 4 response and expression on monocytes decrease rapidly in patients undergoing arterial surgery and are related to preoperative smoking. Shock 2009 31 : 21 7.
50. Serushago B, Issekutz AC, Lee SH, et al. Deficient tumor necrosis factor secretion by cord blood mononuclear cells upon in vitro stimulation with Listeria monocytogenes. J Interferon Cytokine Res 1996 16 : 381 7.
51. Lebouder E, Rey-Nores JE, Rushmere NK, et al. Soluble forms of Toll-like receptor (TLR)2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003 171 : 6680 9.
52. Kuroishi T, Tanaka Y, Sakai A, et al. Human parotid saliva contains soluble toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Mol Immunol 2007 44 : 1969 76.
53. Marchini L, Campos MS, Silva AM, et al. Bacterial diversity in aphthous ulcers. Oral Microbiol Immunol 2007 22 : 225 31.
54. Boras VV, Lukac J, Brailo V, et al. Salivary interleukin-6 and tumor necrosis factor-alpha in patients with recurrent aphthous ulceration. J Oral Pathol Med 2006 35 : 241 3.
55. Yamamoto T, Yoneda K, Ueta E, et al. Serum cytokine levels in patients with oral mucous membrane disorders. J Oral Pathol Med 1991 20 : 275 9.
56. Golenbock DT, Bach RR, Lichenstein H, et al. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells. J Lab Clin Med 1995 125 : 662 71.